Network_Molecular

VISION

ZIELE

The population ages and expects to make use of additional life years at a high level of quality-of-life, at an affordable price tag.
Advancements in medicine will help to make this desire true by

Targeted prevention based on individual prognosis of health risks,
specific and sensitive diagnosis of diseases at early onset,
personalized minimal invasive therapy, real-time monitored,
and careful long-term control.

Progress is fueled by

mankind's exploding scientific understanding of life at the molecular and cell level,
growing insight into the biological functions of the human organism,
achievements in many new technologies - hardware and software -
and exploiting all this through innovative engineering.

Molecular Imaging is a synthesis of all these scientific and technological trends, and shows what kind of disease is where in the body at which stage of its development - much better than nowadays.

Molecular Imaging uses highly sophisticated, innovative tracers to "mark-up" the targeted lesion, the latest breed of medical imaging machines ("scanners") based on various different physical principles, software to produce images with meaningful content, and elaborated clinical protocols for applying these methods safe and in a reproducible manner to patients.

Molecular Imaging will dramatically improve the early diagnosis of cancer, arteriosclerosis, and neuro-degenerative diseases, and may revolutionize the objective diagnosis of mental diseases.

Molecular Imaging is an inevitable enabler for applying new therapeutic pathways like localized drug delivery or stems cell therapy.

Molecular Imaging is also used within the development process of new therapeutic drugs by monitoring their effectiveness in small animals.

There is no doubt: Molecular Imaging - together with its complementary sibling Molecular in-vitro-diagnostics - will be the keystones for a new era of health care.

MISSION

The "Network Molecular Imaging of the German Professional Societies" will contribute to make the above vision true.

It is by its spirit and by its structure a multidisciplinary group

of scientists of different domain knowledge, education and skills (biologists, chemists, physicists, engineers,physicians, ...)
of different roles in the innovation process (basic research, industrial applied R&D, and clinical application)

It serves as a platform of knowledge exchange across the borders of specialized scientific societies for coordination of multidisciplinary work, and thus is complementary to the existing societal structures.

The participance of medical doctors working in radiology, nuclear medicine and oncological departments is crucial. They must first define the "business case" and strategic goals for the applied research, the scientific and industrial groups will then provide new technical solutions, which at the end must be validated by the medical doctors again in clinical trials.

OBJECTIVES

Coordinate research activities contributing to MI
Coordinate and contribute to scientific workshops and conferences
Allocate deficiencies and limits of existing procedures, clinical protocols, quantitative methods, and contribute to standardisation
Formulate the scope and targets of future research
Build liaisons to international societies with similar scope
Interface to other sciences and associations with related scope but different focus (in-vitro-diagnostics, pharma, biotech, micro- and nanotechnologies, infomatics, ...)
Formulate position papers for decision makers on clinical and economic benefits

ZIELE des Interdisziplinären Netzwerkes Molekulare Bildgebung (INMB)

Das “Interdisziplinäre Netzwerk Molekulare Bildgebung” ist ein loser Zusammenschluss von Wissenschaftlern auf diesem und angrenzenden Gebieten aus Naturwissenschaften, klinischen Diszip-linen, einschließlich der dazugehörigen Technologien.

Die Zielsetzungen des Netzwerkes sind:

Koordination und Gestaltung der fachspezifischen wissenschaftlichen Kommunikation bei Konferenzen
Vernetzung von Forschungsaktivitäten
Aufzeigen von Entwicklungsdefiziten
Thesenpapiere zu Chancen, klinischen und ökonomischen Nutzen
Beratung von Förderern
Mitgestaltung von Forschungsprogrammen
Liaison zu entsprechenden internationalen Fachgesellschaften und Gremien.

Das INMB wird bisher von den Fachgesellschaften (FGn)

DEGRO (Deutsche Gesellschaft für Radioonkologie e.V.)
DGBMT (Deutsche Gesellschaft für Biomedizinische Technik im VDE)
DGMP (Deutsche Gesellschaft für Medizinsiche Physik e.V.)
DGN (Deutsche Gesellschaft für Nuklearmedizin e.V.)
DRG (Deutsche Röntgengesellschaft)
ideell unterstützt.

Es möchte die Ziele erreichen mit minimalem bürokratischen und finanziellen Aufwand.
Es plant nicht eine eigene Fachgesellschaft oder Fachzeitschrift zu gründen.
Das INMB soll nicht die Arbeit in spezialisierten Arbeitsgruppen in den etablierten Fachgesellschaften ersetzen, sondern sie ergänzen durch Initiierung, Begleitung und Koordinierung von übergreifenden, multidisziplinären Aktivitäten.

[Home] [News] [Mission] [Members] [Contact] [Workgroups] [Research] [Conferences] [Documents] [Downloads] [Forum] [News] [Links]